Insulin: An endogenous cardioprotector

Current Opinion in Critical Care

Volumn 9, Issue 5, 2003, Pages 375-383

  Das, Undurti N ^a  

^a EFA Sciences LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ACETYLCYSTEINE; ANTIDIABETIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CHLORPROPAMIDE; CYCLOOXYGENASE 2; CYTOKINE; FATTY ACID; FREE RADICAL; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; NITRIC OXIDE; POTASSIUM; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SULFONYLUREA DERIVATIVE; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CARDIOGENIC SHOCK; CATARACT; CONGESTIVE HEART FAILURE; CONVALESCENCE; CRITICAL ILLNESS; DIABETES MELLITUS; DISEASE CONTROL; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFECT; DRUG INFUSION; ENDOTHELIUM CELL; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART PROTECTION; HEART TRANSPLANTATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INFLAMMATION; INSULIN INFUSION; INTENSIVE CARE; KIDNEY INJURY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OPEN HEART SURGERY; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PROPHYLAXIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; QUALITY OF LIFE; REPERFUSION INJURY; RETINOPATHY; REVIEW; SEPSIS; SEPTIC SHOCK; STROKE; SURVIVAL; VISUAL IMPAIRMENT;

ANIMALS; BLOOD GLUCOSE; DIABETIC KETOACIDOSIS; GLUCOSE; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MYOCARDIAL INFARCTION; NITRIC OXIDE; POTASSIUM; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141450649     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200310000-00007     Document Type: Review

References (75)

1. Das UN: Is insulin an anti-inflammatory molecule? Nutrition 2001, 17:409-413.
2. Prospective Diabetes Study UK (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853.
3. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
4. Mohan IK, Das UN: Oxidant stress, anti-oxidants and nitric oxide in non-insulin dependent diabetes mellitus. Med Sci Res 1997, 25:55-57.
5. Das UN, Kumar KV, Mohan IK: Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J Nutr Med 1994, 4:149-155.
6. Nishikawa T, Edelstein D, Du XL, et al.: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 2000, 404:787-790.
7. Giardino I, Edelstein D, Brownlee M: BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation end products in bovine endothelial cells. J Clin Invest 1996,97:1422-1428.
8. Das UN: Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 2000,215:145-152.
9. Laight DW, Kaw AV, Carrier MJ, et al.: Interaction between superoxide anion and nitric oxide in the regulation of vascular endothelial cells. Br J Pharmacol 1998, 124:238-244.
10. Das UN: Nutritional factors in the pathobiology of human essential hypertension. Nutrition 2001, 17:337-346.
11. Mohanty P, Hamouda W, Garg R, et al.: Glucose challenge stimulates reactive oxygen species (ROS) generation by leukocytes. J Clin Endocrinol Metab 2000, 85:2970-2974.
12. Ceriello A, Bortolotti N, Motz E, et al.: Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998, 21:1529-1533.
13. Booth G, Stalker TJ, Lefer AM, et al.: Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol 2001, 280:E848-E856.
14. Dandona P, Aljada A, Mohanty P, et al.: Insulin inhibits intranuclear nuclear factor kappa B and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an inflammatory effect? J Clin Endocrinol Metab 2001, 86:3257-3265.
15. Aljada A, Saadesh R, Assian E, et al.: Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab 2000, 85:2572-2575.
16. Aljada A, Ghanim H, Saadesh R, et al.: Insulin inhibits NFκB and MCP-1 expression human aortic endothelial cells. J Clin Endocrinol Metab 2001, 86:450-453.
17. Das UN: Is insulin an endogenous cardioprotector? Crit Care 2002, 6:389-393. In this review the authors presented arguments that insulin is an endogenous cardioprotective agent because it has antiinflammatory actions and hence is of benefit in AMI, sepsis, and septic shock.
18. Esposito K, Nappo F, Marfella R, et al.: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072. The authors presented evidence that hyperglycemia enhances the concentrations of proinflammatory cytokines and produces oxidative stress.
19. Srinivasan S, Yeh M, Danziger EC, et al.: Glucose regulates monocytes adhesion through endothelial production of interleukins-8. Circulation Res 2003, 92:371-377. In this elegant study, the authors showed that glucose stimulates the production of proinflammatory IL-8 by endothelial cells, which in turn is responsible for the adhesion of monocytes to the endothelial cells. This results in damage to the endothelial cells and inn endothelial dysfunction.
20. Fogh K, Larsen CG, Iversen L, et al.: Interleukin-8 stimulates the formation of 15-hydroxyeicosatetraenoic acid by human neutrophils in vitro. Agents Actions 1992, 35:227-231.
21. Liu S, Manson JE, Buring JE, et al.: Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002, 75:492-498. In this clinical study, authors demonstrated that a high glycemic load enhances the plasma concentrations of C-reactive protein, an indicator of inflammation. Although the concentrations of proinflammatory and antiinflammatory cytokines were not evaluated in this study, it can be concluded on the basis of this and other studies that continued consumption of a high-energy diet induces proinflammatory events that may trigger the development of metabolic syndrome X.
22. Lin Y, Rajala MW, Berger JP, et al.: Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 2001, 276:42077-42083.
23. Fan J, Frey RS, Rahman A, et al.: Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-α-induced NF-κB activation and intercellular adhesion molecule-1 expression in endothelial cells. J Biol Chem 2002, 277:3404-3411.
24. Guzik TJ, Mussa S, Gastaldi D, et al.: Mechanism of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002, 105:1656-1662.
25. Cruikshank N: Coronary thrombosis and myocardial infarction, with glycosuria. BMJ 1931, 1:618-619.
26. Sewdarsen M, Jialal I, Vythilingum S, et al.: Stress hyperglycemia is a predictor of abnormal glucose tolerance in Indian patients with acute myocardial infarction. Diabetes Res 1987, 6:47-49.
27. Oswald GA, Smith CCT, Betteridge DJ, et al.: Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. BMJ 1986, 293:917-922.
28. Yudkin JS, Oswald CA: Hyperglycemia, diabetes and myocardial infarction. Diabetes Med 1987, 4:13-18.
29. Van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367.
30. Oliver MF, Opie LH: Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994, 343:155-158.
31. Cain BS, Harken AH, Meldrum DR: Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and reperfusion. J Mol Cell Cardiol 1999, 31:931-947.
32. Li D, Zhao L, Liu M, et al.: Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am Heart J 1999, 137:1145-1152.
33. Levine B, Kalman J, Mayer L, et al.: Elevated circulating levels of tumor necrosis factor in congestive heart failure. N Engl J Med 1990, 323:236-241.
34. Meldrum DR, Donnahoo KK: Role of TNF in mediating renal insufficiency following cardiac surgery: evidence of a post bypass cardiorenal syndrome. J Surg Res 1999, 85:185-199.
35. Ferrari R: Tumor necrosis factor in CHF: a double facet cytokine. Cardiovasc Res 1998, 37:554-559.
36. Satomi N, Sakurai A, Haranaka K: Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophages. J Natl Cancer Inst 1985, 74:1255-1260.
37. Fraker DL, Merino MJ, Norton JA: Reversal of the toxic effects of cachectin by concurrent insulin administration. Am J Physiol 1989, 256(6 Pt 1):E725-E731.
38. Riedemann NC, Guo R-F, Ward PA: Novel strategies for the treatment of sepsis. Nature Med 2003, 9:517-524.
39. Martin TR: MIF mediation of sepsis. Nature Med 2000, 6:140-141.
40. Das UN: Cytokines, NF-κB, activated protein C, oxidized phospholipids, inducible cyclo-oxygenase eicosanoids, adenosine and insulin in sepsis and septic shock. Critical Care Shock 2003, 6:40-49.
41. Kuboki K, Jiang ZY, Takahara N, et al.: Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000, 101:676-681.
42. Gao F, Gao E, Yue T-L, et al.: Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: The roles of PI3-Kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002, 105:1497-1502. In this elegant in vivo study, it was found that the cardioprotective actions of insulin are due to its ability to enhance endothelial NO generation and antiapoptotic action on myocardial tissue.
43. Boichot E, Sannomiya P, Escofier N, et al.: Endotoxin-induced acute lung injury in rats: role of insulin. Pulm Pharmacol Ther 1999, 12:285-290.
44. Jeschke MG, Einspanier R, Klein D, et al.: Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 2002, 8:443-450. This study showed that insulin suppresses the production of TNF-α, IL-6, and MIF and at the same time enhances that of anti-inflammatory cytokines IL-4 and IL-10.
45. Das UN: Insulin and the critically ill. Crit Care 2002, 6:262-263. In this review the authors summarized the anti-inflammatory actions of insulin and suggested that it could be useful in critically ill, AMI, sepsis, and septic shock.
46. Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: Myocardial depression in sepsis and septic shock. Critical Care 2002, 6 (DOI 10.1186/cc1822).
47. Bronsveld W, van Lambalgen AA, van Velzen D, et al.: Myocardial metabolic and morphometric changes during canine endotoxin shock before and after glucose-insulin-potassium. Cardiovasc Res 1985, 19:455-464.
48. Tuynman HA, Thijs LG, Straub JP, et al.: Effects of glucose-insulin-potassium (GIK) on the position of the oxyhemoglobin dissociation curve, 2.3-diphosphoglycerate, and oxygen consumption in canine endotoxin shock. J Surg Res 1983, 34:246-253.
49. Hinshaw LB, Archer LT, Benjamin B, et al.: Effects of glucose or insulin on myocardial performance in endotoxin shock. Proc Soc Exp Biol Med 1976, 152:529-534.
50. Archer LT, Beller BK, Drake JK, et al.: Reversal of myocardial dysfunction in endotoxin shock with insulin. Can J Physiol Pharmacol 1978, 56:132-138.
51. Chambrier C, Laville M, Rhzioual Berrada K, et al.: Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin Sci 2000, 99:321-328.
52. Lind L, Lithell H: Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival. Clin Intensive Care 1994, 5:100-105.
53. Maitra SR, Wojnar MM, Lang CH: Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock 2000, 13:379-385.
54. Maitra SR, Wang S, Baithwaite CE, et al.: Alterations in glucose-6- phosphatase gene expression in sepsis. J Trauma 2000, 49:38-42.
55. Kim YM, Bombeck CA, Billiar TR: Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999, 84:253-256.
56. Rossig L, Haendeler J, Hermann C, et al.: Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis. J Biol Chem 2000, 275:25502-25507.
57. Mauritz W, Schindler I, Zadrobilek E, et al.: Glucose-potassium-insulin in hypodynamic septic shock. Anaesthetist 1986, 35:623-627.
58. Bronsveld W, van den Bos GC, Thijs LG: Use of glucose-insulin-potassium (GIK) in human septic shock. Crit Care Med 1985, 13:566-570.
59. Zhu P, Lu L, Xu Y, et al.: Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol 2000, 278:H595-H603.
60. Rudez I, Sutlic Z, Husedzinovic I, Biocina B, Ivancan V. The importance of glucose-insulin-potassium with cardiopulmonary bypass prior to cardioplegic arrest in open-heart surgery. Lijed Vjesn 1995, 117(Suppl2):105-106.
61. Girard C, Quentin P, Bouvier H, et al.: Glucose and insulin supply before cardiopulmonary bypass in cardiac surgery: a double-blind study. Ann Thorac Surg 1992, 54:259-263.
62. Lell WA, Nielsen VG, McGiffin DC, et al.: Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. Ann Thorac Surg 2002, 73:1246-1251. This study and [63-65] showed both positive [62,63] and negative [64,65] results on the cardioprotective action of insulin (essentially used as GIK cocktail). These studies emphasize the importance of using the correct dose of insulin to bring about its cardioprotective action. A close look at these studies suggests that an appropriate ratio between insulin and glucose needs to be maintained to protect the myocardium.
63. Bruemmer-Smith S, Avidan MS, Harris B, et al.: Glucose, insulin and potassium for heart protection during cardiac surgery. Br J Anaesth 2002, 88:489-495.
64. Rao V, Christakis GT, Weisel RD, et al., for the ICT Investigators.: The Insulin Cardioplegia Trial: myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 2002, 123:928-935.
65. Diaz-Arya G, Nettle D, Castro P, et al.: Oxidative stress after reperfusion with primary coronary angioplasty: lack of effect of glucose-insulin-potassium infusion. Crit Care Med 2002, 30:417-421.
66. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-778.
67. Christiansen CL, Schurizek BA, Malling B, et al.: Insulin treatment of the insulin-dependent diabetic patient undergoing minor surgery: continuous intravenous infusion compared with subcutaneous administration. Anaesthesia 1988, 43:533-537.
68. Das UN: Possible beneficial action(s) of glucose-insulin-potassium regimen in acute myocardial infarction and inflammatory conditions: a hypothesis. Diabetologia 2000, 43:1081-1082.
69. Diaz R, Paolasso EA, Piegas LS, et al.: Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998, 98:2227-2234.
70. Van Campen CMC, Klein LJ, Visser FC: Glucose-insulin-potassium imaging: the past and the future? Heart Metabol 2001, 12:14-18.
71. Jonassen AK, Sack MN, Mjos OD, et al.: Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell survival signaling. Circ Res 2001, 89:1191-1198.
72. Rao V, Meranta F, Weisel RD, et al.: Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from stimulated ischemia. J Thorac Cardiovasc Surg 1998, 116:485-494.
73. Girard C, Quentin P, Bouvier H, et al.: Glucose and insulin supply before cardiopulmonary bypass in cardiac surgery: a double-blind study. Ann Thorac Surg 1992, 54:259-263.
74. Dandona P, Aljada A, Mohanty P: The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002, 45:924-930. This article and [75] review the mechanisms involved in the anti-inflammatory actions of insulin and propose that insulin also prevents atherosclerosis [74], whereas in [75] it was suggested that insulin may have not only cardioprotective but also neuroprotective actions. Thus, insulin may have a role in the pathobiology of Alzheimer disease and other dementias.
75. Das UN: Insulin and inflammation: further evidence and discussion. Nutrition 2002, 18:526-527.